Navigation Links
Amyotrophic Lateral Sclerosis Association honors Dr. Robert Baloh, M.D.
Date:4/27/2012

LOS ANGELES (April 27, 2012) Robert H. Baloh, MD, PhD, director of Cedars-Sinai Medical Center's Neuromuscular Division, has received the ALS Association Golden West Chapter Commitment to a Cure Award.

Baloh, one of the top doctors and research scientists treating and studying amyotrophic lateral sclerosis (also known as Lou Gehrig's disease), has published groundbreaking discoveries in genetics and molecular biology and is the principal investigator of five projects examining the molecular and cellular basis of ALS and other neuromuscular disorders.

He joined Cedars-Sinai in early 2012 to create one of the most comprehensive ALS treatment and research teams in California, joining Clive Svendsen, PhD, director of the Regenerative Medicine Institute, and Patrick D. Lyden, MD, chair of the Department of Neurology and the Carmen and Louis Warschaw Chair in Neurology.

"I am very honored that the ALS Association chose to recognize our efforts toward developing a cure for ALS. I especially want to acknowledge our patients where ALS runs in their family, whose willingness to work closely with us has been key to our success," Baloh said.

Svendsen said, "We are very proud that Dr. Baloh received this recognition from the ALS Association. He is an outstanding scientist and clinician devoted to solving the mysteries of ALS."

Baloh's research group was one of the first to discover that mutations in the TDP-43 gene cause inherited forms of ALS and frontotemporal lobar degeneration, a type of dementia that can accompany ALS. He also led studies that in 2009 produced the first mouse model of ALS based on the TDP-43 gene. The first new ALS mouse model in 14 years, it is employed by researchers worldwide to study the disease.

Baloh earned his PhD and MD degrees at Washington University School of Medicine in St. Louis and is board certified in both neurology and neuromuscular medicine. Two of his current research projects are funded by the National Institutes of Health/National Institute of Neurological Disorders and Stroke and others are supported by grants from the Muscular Dystrophy Association and Burroughs Wellcome Foundation.  

Even as Baloh and his colleagues seek cures, they work to improve their patients' quality of life. Cedars-Sinai's multidisciplinary ALS clinic recently became the first West Coast site and one of only three nationwide providing an implanted breathing-assist device for ALS patients suffering chronic hypoventilation, the inability to take enough air into the lungs. The device can be used in a hospital, at a rehabilitation center or at home, and unlike an external ventilator, the system is silent.


'/>"/>

Contact: Sandy Van
sandy@prpacific.com
808-526-1708
Cedars-Sinai Medical Center
Source:Eurekalert

Related medicine news :

1. Contralateral prophylactic mastectomy offers limited gains for breast cancer patients
2. War on cancer produces collateral damage to the heart
3. Gay mens bilateral brains better at remembering faces: York U study
4. Kessler Foundation scientist awarded $554,000 for multiple sclerosis employment research
5. Fish Oil Supplements Wont Help in Multiple Sclerosis: Study
6. Experimental Pill for Multiple Sclerosis Shows Promise
7. Experimental Pill May Ease Multiple Sclerosis Disability
8. Diabetes drug halts atherosclerosis progression in HIV-infected patients
9. Researchers discover new culprit in atherosclerosis
10. Multiple Sclerosis May Cause Changes in Thalamus: Study
11. Beneficial or not beneficial: that is the question for IL-1 inhibition in atherosclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... ... 28, 2017 , ... Bill Howe started his sewer and drain company in ... Howe joined the team, the Bill Howe brand was born and they began cultivating ... giving back to the San Diego community in which they worked, lived and were ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation Limited, a leading ... Nova Skin Sciences division, recently announced the launch of Allumière Antiaging Cream, a ... of an anti-aging concentrate. , Anogeissus Leiocarpa Bark Extract and Vitamin ...
(Date:4/27/2017)... ... April 27, 2017 , ... Today, Jefferson Health in Philadelphia ... announced an agreement to create the Jane and Leonard Korman Respiratory Institute in ... Leonard Korman Family Foundation. The collaboration leverages the strengths of each organization and ...
(Date:4/27/2017)... ... 27, 2017 , ... Last night, Christine Collins of New ... for her extraordinary compassion and lifelong dedication to serve others. Since 1997, Home ... the prestigious award each year – identifying a CAREGiver who has exemplified exceptional ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device ... markets with innovative and proprietary products, will release financial ... after the market close on Tuesday, May 2, 2017. ... call and webcast to discuss its financial results the ... p.m. Eastern Time (3:30 p.m. Central Time). Darin ...
(Date:4/18/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 6.35% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
Breaking Medicine Technology: